Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Allergy and Infectious Diseases (NIAID) |
---|---|
Information provided by: | National Institute of Allergy and Infectious Diseases (NIAID) |
ClinicalTrials.gov Identifier: | NCT00032708 |
A double-blind, randomized, dose-response study of four dilutions of Dryvax in previously vaccinated adults in order to assess the clinical success rates, humoral responses, and virus-specific actifity of cytotoxi T cells and interferon-y producing T cells
Condition | Intervention | Phase |
---|---|---|
Smallpox |
Biological: Dryvax |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Double Blind, Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 01-651 |
Study First Received: | March 28, 2002 |
Last Updated: | May 25, 2006 |
ClinicalTrials.gov Identifier: | NCT00032708 |
Health Authority: | United States: Food and Drug Administration |
Virus Diseases Smallpox Poxviridae Infections DNA Virus Infections |